Johnson & Johnson Says It Can Produce 20 Million Doses Of COVID-19 Vaccine By The End Of March


Johnson & Johnson said Tuesday that it can produce 20 million doses of the single-shot coronavirus vaccine by the end of March and has requested emergency clearance from the Food and Drug Administration.

SANOFI PRODUCES JOHNSON & JOHNSON COVID-19 VACCINES

“Assuming the necessary regulatory approvals related to our manufacturing processes, our plan is to begin shipping immediately after emergency use authorization and deliver enough single doses by the end of March to allow vaccination of more than 20 million Americans,” Richard Nettles, vice chairman of medical affairs for Johnson & Johnson’s pharmaceutical unit, Janssen, told the House of Representatives subcommittee on Energy and Commerce. Nettles’ comments were posted before the meeting.

The panel of legislators began hearing testimony from the five companies with contracts to supply COVID-19 injections to the US (Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Novavax) as vaccine supplies remain in short supply in compared to the higher demand for the coveted shots.

A phase 3 trial of the Johnson & Johnson vaccine found that the effectiveness of its injection in fighting moderate to severe COVID-19 infections was 72% in the United States, 66% in Latin America, and 57% in South Africa. , 28 days after vaccination. vaccination, according to the pharmaceutical company.

MODERN PLANS TO INCREASE THE COVID-19 VACCINE DOSE IN EACH VIAL FROM 10 TO 15

The news comes as South Africa continues to battle a relatively new and powerful strain of coronavirus, B.1.315, which has since made its way to the US.

Nettles said the company is “confident” it can supply 100 million single-dose vaccines to the US during the first half of 2021 despite “significant challenges” to increasing production.

Johnson & Johnson recently announced that it would partner with French pharmaceutical giant Sanofi to utilize its facilities and increase vaccine production to reduce the supply gap.

Despite a significant vaccine shortage from all drug suppliers, federal health officials say a total of 700 million doses are expected to be delivered in the US by the end of July. That would be enough to reach the goal of providing enough shots for every American adult.

CLICK HERE TO SEE THE FOX NEWS APP

Associated Press contributed to this report.

Source link